MedTrace Logo

Thromboprophylaxis and Bariatric Surgery

NCT00444652 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2012-07-02

No results posted yet for this study

Summary

This trial is an assessment of the efficacy of three thromboprophylaxis regimens in two types of bariatric surgery.

\- gastric banding and gastric bypass on anti-Xa activity levels

The study includes two groups of 150 patients scheduled for gastric banding or gastric bypass.

Assessment of anti-Xa levels before and 4 hours after the injections from day 0 to 2 in order to determine the best prophylactic regimen allowing expected values ranged between 0.3 and 0.5 IU / ml.

Conditions

  • Thromboembolism

Interventions

DRUG

Enoxaparin

injection of enoxaparin a few time

Sponsors & Collaborators

  • French State

    collaborator UNKNOWN

  • Sanofi

    collaborator INDUSTRY

  • University Hospital, Strasbourg, France

    lead OTHER

Principal Investigators

  • Annick Steib, MD · Hôpitaux Universitaire de Strasbourg

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2012-11-30
Completion
2012-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00444652 on ClinicalTrials.gov